QuantuMDx embarks on £11 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette
NEWCASTLE UPON TYNE, UK, Dec 17 (Bernama-GLOBE NEWSWIRE) —QuantuMDx Group Limited, a UK-based life sciences company developing transformational point-of-care molecular…